Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment

Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment

Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in det...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Toxicology research (Cambridge) 2021-12, Vol.10 (6), p.1077-1084
Hauptverfasser: Wang, Qiang, Wang, Jing, Wang, Jiayou, Ju, Xiaoli, Zhang, Heng
Format: Artikel
Sprache:eng
Schlagworte:
Review
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1084
container_issue 6
container_start_page 1077
container_title Toxicology research (Cambridge)
container_volume 10
creator Wang, Qiang
Wang, Jing
Wang, Jiayou
Ju, Xiaoli
Zhang, Heng
description Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in determining the antitumor mechanism of shikonin and its derivatives, specifically their induction of reactive oxygen species production, inhibition of EGFR and PI3K/AKT signaling pathway activation, inhibition of angiogenesis and induction of apoptosis and necroptosis. We also discuss the application of nanoparticles loaded with shikonin in the targeted therapy of various cancers. Finally, we suggest new strategies for the clinical application of shikonin and its derivatives.
doi_str_mv 10.1093/toxres/tfab107
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8692723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2614754733</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-14ec55b2e1d6d29f5768059616a148756d851840cd4a428d1d620e414b9c726e3</originalsourceid><addsrcrecordid>eNpVkc1r3DAQxUVJ6YY01x6Ljrk4q2_bl0BYkjSQ0ksLvQlZHq_V2JIjyUnz39fLbpZmLjMwv3lv4CH0hZJLSmq-zuFvhLTOnWkoKT-gU0aELITk1clxZr9X6DylP2SpkjDF5Se04qKWSlF2iuB7GMDOg4l4BNsb79KIQ4dT7x6Ddx4737vGZee3OM9jiHgbw0vusfEtnkIGn50ZsJmmwVmTXdhdYGu8hYhzBJPHBfmMPnZmSHB-6Gfo1-3Nz8234uHH3f3m-qGwvCa5oAKslA0D2qqW1Z0sVUVkragyVFSlVG0laSWIbYURrGoXjBEQVDS1LZkCfoau9rrT3IzQ2sU6mkFP0Y0mvupgnH6_8a7X2_CsK1WzkvFF4OIgEMPTDCnr0SULw2A8hDlppqgopSj5Dr3cozaGlCJ0RxtK9C4evY9HH-JZDr7-_9wRfwuD_wPm75B_</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2614754733</pqid></control><display><type>article</type><title>Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Royal Society Of Chemistry Journals 2008-</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Qiang ; Wang, Jing ; Wang, Jiayou ; Ju, Xiaoli ; Zhang, Heng</creator><creatorcontrib>Wang, Qiang ; Wang, Jing ; Wang, Jiayou ; Ju, Xiaoli ; Zhang, Heng</creatorcontrib><description>Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in determining the antitumor mechanism of shikonin and its derivatives, specifically their induction of reactive oxygen species production, inhibition of EGFR and PI3K/AKT signaling pathway activation, inhibition of angiogenesis and induction of apoptosis and necroptosis. We also discuss the application of nanoparticles loaded with shikonin in the targeted therapy of various cancers. Finally, we suggest new strategies for the clinical application of shikonin and its derivatives.</description><identifier>ISSN: 2045-452X</identifier><identifier>ISSN: 2045-4538</identifier><identifier>EISSN: 2045-4538</identifier><identifier>DOI: 10.1093/toxres/tfab107</identifier><identifier>PMID: 34956612</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Review</subject><ispartof>Toxicology research (Cambridge), 2021-12, Vol.10 (6), p.1077-1084</ispartof><rights>The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><rights>The Author(s) 2021. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-14ec55b2e1d6d29f5768059616a148756d851840cd4a428d1d620e414b9c726e3</citedby><cites>FETCH-LOGICAL-c390t-14ec55b2e1d6d29f5768059616a148756d851840cd4a428d1d620e414b9c726e3</cites><orcidid>0000-0003-3123-3889</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692723/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692723/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34956612$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Qiang</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Wang, Jiayou</creatorcontrib><creatorcontrib>Ju, Xiaoli</creatorcontrib><creatorcontrib>Zhang, Heng</creatorcontrib><title>Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment</title><title>Toxicology research (Cambridge)</title><addtitle>Toxicol Res (Camb)</addtitle><description>Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in determining the antitumor mechanism of shikonin and its derivatives, specifically their induction of reactive oxygen species production, inhibition of EGFR and PI3K/AKT signaling pathway activation, inhibition of angiogenesis and induction of apoptosis and necroptosis. We also discuss the application of nanoparticles loaded with shikonin in the targeted therapy of various cancers. Finally, we suggest new strategies for the clinical application of shikonin and its derivatives.</description><subject>Review</subject><issn>2045-452X</issn><issn>2045-4538</issn><issn>2045-4538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkc1r3DAQxUVJ6YY01x6Ljrk4q2_bl0BYkjSQ0ksLvQlZHq_V2JIjyUnz39fLbpZmLjMwv3lv4CH0hZJLSmq-zuFvhLTOnWkoKT-gU0aELITk1clxZr9X6DylP2SpkjDF5Se04qKWSlF2iuB7GMDOg4l4BNsb79KIQ4dT7x6Ddx4737vGZee3OM9jiHgbw0vusfEtnkIGn50ZsJmmwVmTXdhdYGu8hYhzBJPHBfmMPnZmSHB-6Gfo1-3Nz8234uHH3f3m-qGwvCa5oAKslA0D2qqW1Z0sVUVkragyVFSlVG0laSWIbYURrGoXjBEQVDS1LZkCfoau9rrT3IzQ2sU6mkFP0Y0mvupgnH6_8a7X2_CsK1WzkvFF4OIgEMPTDCnr0SULw2A8hDlppqgopSj5Dr3cozaGlCJ0RxtK9C4evY9HH-JZDr7-_9wRfwuD_wPm75B_</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Wang, Qiang</creator><creator>Wang, Jing</creator><creator>Wang, Jiayou</creator><creator>Ju, Xiaoli</creator><creator>Zhang, Heng</creator><general>Oxford University Press</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-3123-3889</orcidid></search><sort><creationdate>20211201</creationdate><title>Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment</title><author>Wang, Qiang ; Wang, Jing ; Wang, Jiayou ; Ju, Xiaoli ; Zhang, Heng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-14ec55b2e1d6d29f5768059616a148756d851840cd4a428d1d620e414b9c726e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Qiang</creatorcontrib><creatorcontrib>Wang, Jing</creatorcontrib><creatorcontrib>Wang, Jiayou</creatorcontrib><creatorcontrib>Ju, Xiaoli</creatorcontrib><creatorcontrib>Zhang, Heng</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Toxicology research (Cambridge)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Qiang</au><au>Wang, Jing</au><au>Wang, Jiayou</au><au>Ju, Xiaoli</au><au>Zhang, Heng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment</atitle><jtitle>Toxicology research (Cambridge)</jtitle><addtitle>Toxicol Res (Camb)</addtitle><date>2021-12-01</date><risdate>2021</risdate><volume>10</volume><issue>6</issue><spage>1077</spage><epage>1084</epage><pages>1077-1084</pages><issn>2045-452X</issn><issn>2045-4538</issn><eissn>2045-4538</eissn><abstract>Shikonin is one of the major bioactive components of . It has a good killing effect in a variety of tumor cells. Its antitumor effect involves multiple targets and pathways and has received extensive attention and study in recent years. In this review, we systematically review recent progress in determining the antitumor mechanism of shikonin and its derivatives, specifically their induction of reactive oxygen species production, inhibition of EGFR and PI3K/AKT signaling pathway activation, inhibition of angiogenesis and induction of apoptosis and necroptosis. We also discuss the application of nanoparticles loaded with shikonin in the targeted therapy of various cancers. Finally, we suggest new strategies for the clinical application of shikonin and its derivatives.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34956612</pmid><doi>10.1093/toxres/tfab107</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3123-3889</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2045-452X
ispartof Toxicology research (Cambridge), 2021-12, Vol.10 (6), p.1077-1084
issn 2045-452X
2045-4538
2045-4538
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8692723
source Oxford University Press Journals All Titles (1996-Current); Royal Society Of Chemistry Journals 2008-; PubMed Central; Alma/SFX Local Collection
subjects Review
title Molecular mechanism of shikonin inhibiting tumor growth and potential application in cancer treatment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T18%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20mechanism%20of%20shikonin%20inhibiting%20tumor%20growth%20and%20potential%20application%20in%20cancer%20treatment&rft.jtitle=Toxicology%20research%20(Cambridge)&rft.au=Wang,%20Qiang&rft.date=2021-12-01&rft.volume=10&rft.issue=6&rft.spage=1077&rft.epage=1084&rft.pages=1077-1084&rft.issn=2045-452X&rft.eissn=2045-4538&rft_id=info:doi/10.1093/toxres/tfab107&rft_dat=%3Cproquest_pubme%3E2614754733%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2614754733&rft_id=info:pmid/34956612&rfr_iscdi=true